The CDSN antibody targets the corneodesmosin protein (CDSN), a 52-65 kDa glycoprotein essential for epidermal barrier integrity. It is available in polyclonal forms from multiple suppliers, including Proteintech and Assay Genie, with applications in Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and ELISA.
| Antibody Clone | Immunogen | Reactivity | Applications | Host/Isotype |
|---|---|---|---|---|
| 13184-1-AP (Proteintech) | CDSN fusion protein Ag3854 | Human, Mouse | WB, IHC, IF, ELISA | Rabbit/IgG |
| 27953-1-AP (Proteintech) | CDSN fusion protein Ag27688 | Human, Mouse | WB, IHC, IF, ELISA | Rabbit/IgG |
| CAB14602 (Assay Genie) | CD300A (note: mislabeled as CDSN) | Human | WB | Rabbit/IgG |
Note: The CAB14602 antibody (Assay Genie) appears to target CD300A, not CDSN, suggesting a potential labeling error .
Ovarian Cancer (OC): CDSN is overexpressed in OC tissues and correlates with poor prognosis. Knockdown experiments using the 13184-1-AP antibody demonstrated reduced OC cell proliferation and increased apoptosis, suggesting CDSN as a therapeutic target .
Immune Microenvironment: High CDSN expression in OC is linked to immune infiltration, particularly in antigen-presenting cells (APCs), as validated by IHC and flow cytometry .
Psoriasis: Increased CDSN expression is observed in lesional psoriasis, extending into the stratum spinosum compared to normal skin .
Atopic Dermatitis (AD): Staphylococcus aureus binds to CDSN’s N-terminal region, with higher accessibility in low-NMF corneocytes. Blocking this region with antibodies reduces bacterial adhesion .
The CDSN gene (NCBI Gene ID: 1041) maps to chromosome 6 (NC_000006.12) and encodes a protein critical for corneodesmosome stability. Mutations in CDSN are associated with genodermatoses, including inflammatory peeling skin syndrome .
| Application | Dilution Range |
|---|---|
| Western Blot (WB) | 1:500–1:3000 |
| Immunohistochemistry (IHC) | 1:150–1:600 |
Ovarian Cancer: CDSN knockdown reduces cell proliferation by 30–40% in SKOV3 and HEY cells .
Psoriasis: Lesional skin shows 3-fold higher CDSN immunoreactivity in the stratum spinosum compared to normal skin .
CDSN expression levels, detected via IHC, correlate with immune infiltration in OC (AUC > 0.8 for diagnostic accuracy) .
Corneodesmosin (CDSN) is a protein that plays a critical role in the structure and function of the epidermis. It is a component of corneodesmosomes, which are specialized cell junctions that hold together the cells of the stratum corneum, the outermost layer of skin. CDSN is essential for the integrity of the epidermal barrier, which protects the body from environmental insults and prevents water loss.
Mutations in the CDSN gene are associated with several skin disorders, including:
Research has also shown that CDSN is involved in:
Here are some relevant research studies: